Hepatocyte growth factor inhibits amiloride-sensitive Na+ channel function in cystic fibrosis airway epithelium in vitro

B. Q. Shen, Jonathan Widdicombe, R. J. Mrsny

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cystic fibrosis (CF) airway epithelial cells have a reduced cAMP-dependent Cl- conductance channel (CFTR) function but an increased level of amiloride-sensitive Na+ channel (ENaC) activity. Recently expression of the α-subunit of the ENaC protein complex was shown to be down-regulated by activation of the extracellular signal-regulated protein kinase (ERK) pathway. In the present study we have examined the actions of a potent regulator of the ERK pathway, recombinant human hepatocyte growth factor (rhHGF), on the function of ENaC in confluent, polarized monolayers of both primary cultures of CF airway cells and an SV40-transformed CF nasal epithelial cell line (JME CF/15). Treatment of JME/CF 15 cells with rhHGF at concentrations of 100 ng/ml and above was found to dramatically decrease the activity of amiloride-sensitive Na+ transport. This effect required basolateral exposure of the cytokine. Addition of 100 ng/ml rhHGF to JME/CF 15 cells decreased I(eq) with a t(1/2) of ~ 18 h, with a maximal inhibition of ~ 90% by 36 h. By 48 h, stimulation with rhHGF induced a down-regulation of its receptor, c-met, expressed in these cells. The decrease in I(eq) of JME/CF 15 monolayers was not immediatelly reversed upon removal of rhHGF. Treatment with rhHGF did not appear to affect monolayer resistances nor Cl- currents induced by mediators such as isoproterenol, histamine or bradykinin. Studies with primary cultures of CF airway cell sheets demonstrated comparable sensitivity and time-course properties for the inhibition of amiloride-sensitive currents following rhHGF addition. These observations are consistent with the possible application of an extracellular signalling molecule, such as the cytokine HGF, to reduce the abnormally high activity of amiloride-sensitive Na+ ion channels observed in CF airway cells.

Original languageEnglish (US)
Pages (from-to)157-164
Number of pages8
JournalPulmonary Pharmacology and Therapeutics
Volume12
Issue number3
DOIs
StatePublished - Jun 1999
Externally publishedYes

Fingerprint

Hepatocyte Growth Factor
Amiloride
Cystic Fibrosis
Epithelium
Monolayers
MAP Kinase Signaling System
Cytokines
Epithelial Cells
Induced currents
Bradykinin
In Vitro Techniques
human HGF protein
Ion Channels
Isoproterenol
Protein Kinases
Histamine
Extracellular Signal-Regulated MAP Kinases
Protein Subunits
Nose
Chemical activation

Keywords

  • Amiloride
  • Cystic fibrosis
  • ENaC
  • Hepatocyte growth factor

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Pharmacology

Cite this

Hepatocyte growth factor inhibits amiloride-sensitive Na+ channel function in cystic fibrosis airway epithelium in vitro. / Shen, B. Q.; Widdicombe, Jonathan; Mrsny, R. J.

In: Pulmonary Pharmacology and Therapeutics, Vol. 12, No. 3, 06.1999, p. 157-164.

Research output: Contribution to journalArticle

@article{8f5ed2ab330848ca93afd2fa8a3971a0,
title = "Hepatocyte growth factor inhibits amiloride-sensitive Na+ channel function in cystic fibrosis airway epithelium in vitro",
abstract = "Cystic fibrosis (CF) airway epithelial cells have a reduced cAMP-dependent Cl- conductance channel (CFTR) function but an increased level of amiloride-sensitive Na+ channel (ENaC) activity. Recently expression of the α-subunit of the ENaC protein complex was shown to be down-regulated by activation of the extracellular signal-regulated protein kinase (ERK) pathway. In the present study we have examined the actions of a potent regulator of the ERK pathway, recombinant human hepatocyte growth factor (rhHGF), on the function of ENaC in confluent, polarized monolayers of both primary cultures of CF airway cells and an SV40-transformed CF nasal epithelial cell line (JME CF/15). Treatment of JME/CF 15 cells with rhHGF at concentrations of 100 ng/ml and above was found to dramatically decrease the activity of amiloride-sensitive Na+ transport. This effect required basolateral exposure of the cytokine. Addition of 100 ng/ml rhHGF to JME/CF 15 cells decreased I(eq) with a t(1/2) of ~ 18 h, with a maximal inhibition of ~ 90{\%} by 36 h. By 48 h, stimulation with rhHGF induced a down-regulation of its receptor, c-met, expressed in these cells. The decrease in I(eq) of JME/CF 15 monolayers was not immediatelly reversed upon removal of rhHGF. Treatment with rhHGF did not appear to affect monolayer resistances nor Cl- currents induced by mediators such as isoproterenol, histamine or bradykinin. Studies with primary cultures of CF airway cell sheets demonstrated comparable sensitivity and time-course properties for the inhibition of amiloride-sensitive currents following rhHGF addition. These observations are consistent with the possible application of an extracellular signalling molecule, such as the cytokine HGF, to reduce the abnormally high activity of amiloride-sensitive Na+ ion channels observed in CF airway cells.",
keywords = "Amiloride, Cystic fibrosis, ENaC, Hepatocyte growth factor",
author = "Shen, {B. Q.} and Jonathan Widdicombe and Mrsny, {R. J.}",
year = "1999",
month = "6",
doi = "10.1006/pupt.1999.9999",
language = "English (US)",
volume = "12",
pages = "157--164",
journal = "Pulmonary Pharmacology and Therapeutics",
issn = "1094-5539",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Hepatocyte growth factor inhibits amiloride-sensitive Na+ channel function in cystic fibrosis airway epithelium in vitro

AU - Shen, B. Q.

AU - Widdicombe, Jonathan

AU - Mrsny, R. J.

PY - 1999/6

Y1 - 1999/6

N2 - Cystic fibrosis (CF) airway epithelial cells have a reduced cAMP-dependent Cl- conductance channel (CFTR) function but an increased level of amiloride-sensitive Na+ channel (ENaC) activity. Recently expression of the α-subunit of the ENaC protein complex was shown to be down-regulated by activation of the extracellular signal-regulated protein kinase (ERK) pathway. In the present study we have examined the actions of a potent regulator of the ERK pathway, recombinant human hepatocyte growth factor (rhHGF), on the function of ENaC in confluent, polarized monolayers of both primary cultures of CF airway cells and an SV40-transformed CF nasal epithelial cell line (JME CF/15). Treatment of JME/CF 15 cells with rhHGF at concentrations of 100 ng/ml and above was found to dramatically decrease the activity of amiloride-sensitive Na+ transport. This effect required basolateral exposure of the cytokine. Addition of 100 ng/ml rhHGF to JME/CF 15 cells decreased I(eq) with a t(1/2) of ~ 18 h, with a maximal inhibition of ~ 90% by 36 h. By 48 h, stimulation with rhHGF induced a down-regulation of its receptor, c-met, expressed in these cells. The decrease in I(eq) of JME/CF 15 monolayers was not immediatelly reversed upon removal of rhHGF. Treatment with rhHGF did not appear to affect monolayer resistances nor Cl- currents induced by mediators such as isoproterenol, histamine or bradykinin. Studies with primary cultures of CF airway cell sheets demonstrated comparable sensitivity and time-course properties for the inhibition of amiloride-sensitive currents following rhHGF addition. These observations are consistent with the possible application of an extracellular signalling molecule, such as the cytokine HGF, to reduce the abnormally high activity of amiloride-sensitive Na+ ion channels observed in CF airway cells.

AB - Cystic fibrosis (CF) airway epithelial cells have a reduced cAMP-dependent Cl- conductance channel (CFTR) function but an increased level of amiloride-sensitive Na+ channel (ENaC) activity. Recently expression of the α-subunit of the ENaC protein complex was shown to be down-regulated by activation of the extracellular signal-regulated protein kinase (ERK) pathway. In the present study we have examined the actions of a potent regulator of the ERK pathway, recombinant human hepatocyte growth factor (rhHGF), on the function of ENaC in confluent, polarized monolayers of both primary cultures of CF airway cells and an SV40-transformed CF nasal epithelial cell line (JME CF/15). Treatment of JME/CF 15 cells with rhHGF at concentrations of 100 ng/ml and above was found to dramatically decrease the activity of amiloride-sensitive Na+ transport. This effect required basolateral exposure of the cytokine. Addition of 100 ng/ml rhHGF to JME/CF 15 cells decreased I(eq) with a t(1/2) of ~ 18 h, with a maximal inhibition of ~ 90% by 36 h. By 48 h, stimulation with rhHGF induced a down-regulation of its receptor, c-met, expressed in these cells. The decrease in I(eq) of JME/CF 15 monolayers was not immediatelly reversed upon removal of rhHGF. Treatment with rhHGF did not appear to affect monolayer resistances nor Cl- currents induced by mediators such as isoproterenol, histamine or bradykinin. Studies with primary cultures of CF airway cell sheets demonstrated comparable sensitivity and time-course properties for the inhibition of amiloride-sensitive currents following rhHGF addition. These observations are consistent with the possible application of an extracellular signalling molecule, such as the cytokine HGF, to reduce the abnormally high activity of amiloride-sensitive Na+ ion channels observed in CF airway cells.

KW - Amiloride

KW - Cystic fibrosis

KW - ENaC

KW - Hepatocyte growth factor

UR - http://www.scopus.com/inward/record.url?scp=0033150137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033150137&partnerID=8YFLogxK

U2 - 10.1006/pupt.1999.9999

DO - 10.1006/pupt.1999.9999

M3 - Article

VL - 12

SP - 157

EP - 164

JO - Pulmonary Pharmacology and Therapeutics

JF - Pulmonary Pharmacology and Therapeutics

SN - 1094-5539

IS - 3

ER -